Optimizing Psychiatry Prior Authorization Workflows: Addressing eviCore Integration and Specialty-Specific Needs

Klivira streamlines complex prior authorization processes across specialties. For psychiatry, this includes navigating unique clinical criteria and documentation, while our platform also supports integration with benefit managers like eviCore for their respective domains.

Prior authorization in psychiatry presents distinct challenges, from managing time-sensitive admissions to adhering to evolving clinical guidelines. Revenue cycle directors and prior authorization coordinators require solutions that not only streamline these complex workflows but also integrate seamlessly with diverse payer systems and benefit managers. Klivira provides a comprehensive platform designed to meet these demands, offering robust capabilities for psychiatry PA while accommodating integration needs for entities like eviCore Healthcare.

The Unique Landscape of Psychiatry Prior Authorization

Psychiatric and behavioral health services are subject to intensive prior authorization, often requiring expedited decisions for inpatient and residential admissions. The complexity is amplified by continuous concurrent review for extended stays, adherence to frameworks like ASAM Criteria for substance use disorder (SUD) treatment, and specific documentation for specialty medications and advanced therapies. Klivira's platform is engineered to address these unique operational demands.

High-Volume Prior Authorization Triggers in Psychiatry

Inpatient psychiatric admission and continued stay, often requiring InterQual or MCG behavioral criteria.
Partial Hospitalization (PHP) and Intensive Outpatient (IOP) programs, including concurrent review.
Residential treatment for SUD and eating disorders, among the most heavily managed levels of care.
Specialty psychiatric medications such as long-acting injectable antipsychotics (e.g., paliperidone palmitate), esketamine (Spravato), brexanolone (Zulresso), and zuranolone (Zurzuvae).
Electroconvulsive Therapy (ECT) and Transcranial Magnetic Stimulation (TMS), typically requiring documentation of failed medication trials.
Esketamine / Ketamine clinics, with varying payer policies and FDA REMS-specific PA paths.

Navigating Documentation Requirements and Denial Reasons

Accurate and comprehensive documentation is paramount in psychiatry PA. Payers frequently require DSM-5-TR diagnoses, severity scales like PHQ-9 and GAD-7, safety risk assessments, and evidence of prior levels of care or failed medication trials. Common denial reasons include ASAM level mismatches, insufficient step-therapy documentation for TMS or specialty injectables, and concurrent review denials for continued stays. Klivira's intelligent workflows guide staff in collecting necessary data, reducing common denial triggers.

Addressing eviCore Integration within a Comprehensive PA Strategy

While eviCore Healthcare is primarily known for managing benefits in areas like radiology, cardiology, and oncology, Klivira's architecture is designed for broad integration with various benefit managers and payer portals. Our platform ensures that clinics and health systems can manage all prior authorization workflows from a single interface. This includes connecting to eviCore for its specific benefit management categories, while simultaneously providing deep, specialty-specific automation for complex psychiatry prior authorizations across other payers and channels.

Klivira's Solution for Psychiatry Prior Authorization

Klivira's platform provides specialized support for behavioral health. This includes ASAM-criteria-aware level-of-care logic, automated flagging of potential Mental Health Parity and Addiction Equity Act (MHPAEA) issues when payer criteria appear overly restrictive, and robust concurrent-review workflows for inpatient and residential continued stays. Our system also automates the documentation required for TMS step-therapy, streamlining processes and enhancing approval rates for critical psychiatric treatments.

Seamless EMR and Payer Touchpoints for Mental Health Services

Klivira integrates directly with leading EMR systems via SMART on FHIR, enabling prior authorization requests to be initiated directly from clinical workflows. Our platform connects to payer portals, X12 278, and ePA channels, ensuring that documentation—including DSM-5-TR diagnoses, PHQ-9 scores, and ASAM dimension data—is transmitted efficiently. This comprehensive connectivity reduces manual effort and accelerates approval times for psychiatric services.

Frequently asked questions

How does Klivira handle the unique documentation for psychiatry prior authorizations?

Klivira's platform incorporates intelligent workflows that guide users through collecting specific documentation required for psychiatric services, such as DSM-5-TR diagnoses, PHQ-9, GAD-7, Beck scales, and ASAM Criteria. It ensures that necessary evidence, like failed antidepressant trials for TMS or prior oral medication trials for specialty injectables, is systematically captured and submitted.

Can Klivira manage concurrent reviews for inpatient psychiatric stays?

Yes, Klivira is designed to manage the continuous concurrent review process for inpatient and residential psychiatric admissions. Our system supports periodic continued-stay reviews, flagging upcoming deadlines and prompting for the required clinical updates based on criteria like InterQual or MCG behavioral health guidelines.

What is Klivira's approach to integrating with benefit managers like eviCore?

Klivira offers a unified platform that integrates with a wide array of payers and benefit managers. While eviCore Healthcare is prominent in areas like radiology benefit management, Klivira's system provides the flexibility to connect with such entities for their specific service lines, alongside comprehensive, specialty-specific automation for psychiatry prior authorizations across other relevant payers.

How does Klivira address parity act considerations in behavioral health PA?

Klivira's policy engine includes logic to flag potential Mental Health Parity and Addiction Equity Act (MHPAEA) violations. When payer criteria for behavioral health services appear more restrictive than comparable medical-surgical benefits, the system can highlight these discrepancies, empowering your compliance team to evaluate and address them.

Does Klivira support prior authorization for specialty psychiatric medications like esketamine?

Yes, Klivira supports prior authorization for specialty psychiatric medications, including those with restricted dispensing like esketamine (Spravato) and brexanolone (Zulresso). Our platform helps ensure that all FDA REMS documentation and payer-specific requirements, such as diagnosis confirmation and prior oral medication trials, are met for successful submission.